| Symptom Management for Irritable Bowel Syndrome (NCT02079857) | NYU Langone Health | 2012-11-01 |
| 25-hydroxyvitamin D and Fatigue: The VITALITY Study (NCT01718925) | Ostfold Hospital Trust | 2012-10-01 |
| Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms (NCT01728610) | Danisco | 2012-10-01 |
| Sucrose Breath Test to Determine Intestinal Permeability in IBS (NCT01674088) | Metabolic Solutions Inc. | 2012-10-01 |
| Evaluating and Treating Potential Research Participants With Digestive Disorders (NCT01736280) | National Institute of Nursing Research (NINR) | 2012-09-17 |
| Gluten-free Diet in Irritable Bowel Syndrome (NCT02528929) | Sheffield Teaching Hospitals NHS Foundation Trust | 2012-09-01 |
| Phase I Clinical Trial of DA-6886 in Healthy Male Subjects (NCT01633723) | Dong-A ST Co., Ltd. | 2012-08-01 |
| Efficacy of Gralise® for Chronic Pelvic Pain (NCT01678911) | Shirley Ryan AbilityLab | 2012-08-01 |
| Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D (NCT01638208) | Asian Institute of Gastroenterology, India | 2012-08-01 |
| Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST) (NCT02330029) | Macrohard Institute of Health | 2012-08-01 |
| Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome (NCT01545037) | Bio-K Plus International Inc. | 2012-07-01 |
| Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome (NCT01624610) | University of Michigan | 2012-07-01 |
| Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome (NCT01632488) | Shandong University | 2012-06-01 |
| Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy (NCT02737410) | Medical University of Vienna | 2012-06-01 |
| Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (NCT01553747) | Furiex Pharmaceuticals, Inc | 2012-05-29 |
| Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (NCT01553591) | Furiex Pharmaceuticals, Inc | 2012-05-29 |
| A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome (NCT01641224) | University of Minnesota | 2012-05-01 |
| Milnacipran (Savella) in Irritable Bowel Syndrome (IBS) (NCT01471379) | Spencer Dorn, MD, MPH | 2012-04-01 |
| Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome (NCT01574209) | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 2012-04-01 |
| Mesalazine Treatment in IBS (The MIBS Study) (NCT01699438) | Hans Törnblom | 2012-04-01 |
| Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study (NCT02077699) | SOFAR S.p.A. | 2012-03-01 |
| Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study (NCT02033161) | Karolinska Institutet | 2012-03-01 |
| Effect of Pentoxifylline on Tight Junctions (TJs) of Intestinal Mucosa in Patients With Irritable Bowel Syndrome(IBS) (NCT01542268) | Hospital Universitario de Canarias | 2012-03-01 |
| Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome (NCT02391220) | Clinres Farmacija d.o.o. | 2012-02-01 |
| A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (NCT01494233) | Lexicon Pharmaceuticals | 2012-02-01 |
| Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder (NCT01551225) | Maastricht University Medical Center | 2012-01-01 |
| Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome (NCT01613456) | Lesaffre International | 2011-12-01 |
| Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome (NCT01629212) | Daewoong Pharmaceutical Co. LTD. | 2011-12-01 |
| Comparative Efficacy and Safety of Fenoverine (NCT01507922) | Bukwang Pharmaceutical | 2011-12-01 |
| Welfare Benefits in Functional Somatic Disorders (NCT05611606) | University of Aarhus | 2011-11-10 |
| Psychological Risk Factors for Functional Somatic Disorders (NCT05631860) | University of Aarhus | 2011-11-10 |
| Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome (NCT01529567) | Karolinska Institutet | 2011-11-01 |
| Small and Large Bowel Transit Tests Using MRI (Study 1) (NCT01534507) | University of Nottingham | 2011-11-01 |
| The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS) (NCT01483287) | Sahlgrenska University Hospital | 2011-11-01 |
| Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome (NCT02270268) | Nanjing PLA General Hospital | 2011-11-01 |
| An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects (NCT01411800) | Lexicon Pharmaceuticals | 2011-08-01 |
| Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome (NCT01418066) | Universität Duisburg-Essen | 2011-08-01 |
| The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome (NCT01418053) | Universität Duisburg-Essen | 2011-08-01 |
| Probiotics in the Treatment of Irritable Bowel Syndrome (NCT01837485) | Islamic Azad University, Najafabad Branch | 2011-08-01 |
| 1H-19F Gastrointestinal MRI in Health and IBS (NCT01347918) | University of Zurich | 2011-07-01 |
| Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder (NCT01337609) | Massachusetts General Hospital | 2011-06-01 |
| Effect of Probiotic Supplement on Bowel Function (NCT01475929) | Danisco | 2011-06-01 |
| Effect of Herbal Extract Granules Combined With Probiotics on Irritable Bowel Syndrome With Diarrhea (NCT01342718) | Kyunghee University Medical Center | 2011-04-01 |
| The Effect of Coltect (Selenium, Curcumin and Green Tea) on Irritable Bowel Syndrome (NCT01167673) | NAFTALI TIMNA | 2011-04-01 |
| Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome (NCT01331213) | Mayo Clinic | 2011-04-01 |
| Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome. (NCT01297556) | Michigan Gastroenterology Institute | 2011-04-01 |
| Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. (NCT01517516) | University of California, Los Angeles | 2011-03-01 |
| Female Chronic Pelvic Pain (NCT01255345) | Copenhagen University Hospital at Herlev | 2011-01-01 |
| Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain (NCT01269671) | Medical College of Wisconsin | 2011-01-01 |
| Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome (NCT01276626) | Société des Produits Nestlé (SPN) | 2011-01-01 |
| Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction (NCT00977587) | University of Nottingham | 2011-01-01 |
| Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome (NCT01886781) | University of Stellenbosch | 2011-01-01 |
| The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population (NCT01286597) | Sir Run Run Shaw Hospital | 2011-01-01 |
| An Assessment of Cognitive Function in Irritable Bowel Syndrome (NCT01304355) | University College Cork | 2011-01-01 |
| Alpha-galactosidase Enzyme and Irritable Bowel Syndrome (NCT01243853) | Verman Oy Ab | 2010-12-01 |
| Application of Chemical Sensors for Diagnosis of Inflammatory Bowel Diseases and Irritable Bowel Syndrome by Respiratory Samples (NCT01242163) | Rambam Health Care Campus | 2010-12-01 |
| Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation (NCT01162863) | University of Michigan | 2010-11-01 |
| A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients (NCT01274000) | Astellas Pharma Inc | 2010-11-01 |
| Irritable Bowel Syndrome Evaluation and Treatment in Primary Care (NCT01641341) | American Academy of Family Physicians | 2010-11-01 |
| LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (NCT01257477) | Prometheus Laboratories | 2010-11-01 |
| Prognostic Indicators as Provided by the EPIC ClearView (NCT01476995) | Epic Research & Diagnostics, Inc. | 2010-09-01 |
| Probiotics in Irritable Bowel Syndrome (NCT00846170) | Meir Medical Center | 2010-09-01 |
| Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome (NCT00738920) | State University of New York at Buffalo | 2010-08-01 |
| Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome (NCT01139736) | Chinese University of Hong Kong | 2010-07-01 |
| Mindfulness-Based Stress Reduction and the Microbiome (NCT01619384) | Seattle Institute for Biomedical and Clinical Research | 2010-07-01 |
| Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders (NCT01099111) | King Fahad Medical City | 2010-07-01 |
| The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study (NCT01412372) | University of Utah | 2010-06-01 |
| Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS) (NCT01149200) | Targacept Inc. | 2010-05-01 |
| Effects of Activia in IBS (NCT01252550) | Sahlgrenska University Hospital | 2010-05-01 |
| Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) (NCT01176227) | The Canadian College of Naturopathic Medicine | 2010-05-01 |
| Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea (NCT01130272) | Furiex Pharmaceuticals, Inc | 2010-04-28 |
| Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal (NCT01114113) | Money, Mary E., M.D. | 2010-04-01 |
| Intestinal Microecology in Chronic Constipation (NCT00934479) | Mayo Clinic | 2010-04-01 |
| Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) (NCT00934973) | Hazel Everitt | 2010-04-01 |
| Pediatric Alliance for International Neurogastrointestinal Functional Research (NCT01099787) | Nationwide Children's Hospital | 2010-04-01 |
| Irritable Bowel Syndrome and Lactibiane Tolerance (NCT01529359) | PiLeJe | 2010-03-24 |
| Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) (NCT01327300) | University of Florida | 2010-03-01 |
| A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D) (NCT01076699) | Revogenex, Inc. | 2010-03-01 |
| A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome (NCT00977197) | Mayo Clinic | 2010-03-01 |
| MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS (NCT01280864) | Augusta University | 2010-03-01 |
| Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients (NCT01370720) | MARIA CRISTINA COMELLI | 2010-02-01 |
| Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China (NCT01060527) | Xi'an Jiaotong University | 2010-01-01 |
| Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial (NCT01047800) | Chinese University of Hong Kong | 2010-01-01 |
| Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained Symptoms (NCT01631500) | Göteborg University | 2010-01-01 |
| Iyengar Yoga for Young People With Irritable Bowel Syndrome (NCT01107977) | University of California, Los Angeles | 2010-01-01 |
| Aloe Vera in Irritable Bowel Syndrome (NCT01400048) | Sahlgrenska University Hospital | 2010-01-01 |
| Observational Study of Control Participants for the MAPP Research Network (NCT01098292) | University of Pennsylvania | 2009-12-01 |
| Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS) (NCT01404923) | Laboratoires Mayoly Spindler | 2009-12-01 |
| Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome (NCT01018498) | Baylor College of Medicine | 2009-10-01 |
| Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome (NCT01088971) | Cell Biotech Co., Ltd. | 2009-10-01 |
| Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists (NCT01144832) | KU Leuven | 2009-10-01 |
| Cognitive Behavior Therapy (CBT) Compared to Stress Management for Irritable Bowel Syndrome (NCT01051973) | Karolinska Institutet | 2009-10-01 |
| Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome (NCT01786109) | Michael Camilleri | 2009-09-01 |
| Maastricht IBS Cohort (NCT00775060) | Maastricht University Medical Center | 2009-09-01 |
| Safety Study of Probiotics in Adults With Irritable Bowel Syndrome (NCT00971711) | Baylor College of Medicine | 2009-09-01 |
| An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder (NCT00961298) | West Penn Allegheny Health System | 2009-09-01 |
| Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) (NCT01253408) | Mayo Clinic | 2009-09-01 |
| Comparing of the Gastrointestinal Motility in Irritable Bowel Syndrome (IBS) Patients With Healthy Volunteers (NCT00957398) | University of Aarhus | 2009-08-01 |
| Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type） (NCT00948870) | Shanghai University of Traditional Chinese Medicine | 2009-08-01 |
| Acupuncture/Moxibustion for Irritable Bowel Syndrome (IBS) (NCT00945074) | New York University | 2009-07-01 |